No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Having Clinicians at the Table is Essential When Building & Advancing Digital Health Technologies and Innovations

Editor: What To Know

  • Even though EMR platforms have become a standard operational platform in most healthcare settings, they will continue to require additional enhancements and health data integrations from digital health companies to make it the end-to-end platform needed for clinical decision-making and delivering enhanced patient outcomes.
  • To discover the reason for this explosive growth in digital health integrations, we need to take a step back in time, review the start clinical pushback and then look at the current situation.
  • While it is true that digital health and patient-care-focused technologies have steadily grown over the last decade with tools like EMR, telemedicine, and consumer/patient-centric apps, the actual acceleration has been in digital health technologies, health-based applications, and digital-tech based integrations over the last five years.

By Arti Bedi Pullins, Founder of Pundit Consultantz

While it is true that digital health and patient-care-focused technologies have steadily grown over the last decade with tools like EMR, telemedicine, and consumer/patient-centric apps, the actual acceleration has been in digital health technologies, health-based applications, and digital-tech based integrations over the last five years.

To discover the reason for this explosive growth in digital health integrations, we need to take a step back in time, review the start clinical pushback and then look at the current situation. EMR ideation first came out in the 1960s when it was postulated by Larry Weed with the simple suggestion to record patient information electronically instead of paper. It wasn’t until 2009, after loads of debate and the adoption of incentives, that EMR was finally embraced. Nearly 40 years after Weed’s thoughts, technology eventually advanced enough to consider clinical workflows to solve real patient care problems. Fast-forward to 2022, where over 86 percent of office-based and 94 percent of hospital-based physicians currently use EMR at the center of every clinical workflow, patient engagement and tactic, and patient monitoring system.

Today, clinicians typically prefer all-new patient-related data feed directly into their EMR systems for better patient health alignment and overall outcomes.

The key lesson learned for EMR’s slow growth into healthcare is to have clinicians at the table when making overall digital health, digital technologies, and healthcare-based technology innovations. That said, this collaboration is still not as oblivious as it sounds.

Look at IBM’s Watson Health and its stardom to stardust fall. One of the critical reasons that Watson failed was the lack of physician, clinician, and healthcare data-scientist involvement and the lack of alignment on how patient data collected by IBM would have been used for treatment and therapies. IBM lacked alignment between technology, health data, patient needs, and real-world clinical use-cases to continue to develop its AI for better care decisions.

Clinical teams are at the center of care, delivering personalized treatments and ultimately improving patient outcomes, which is why getting them engaged earlier can further help accelerate both the development and adoption of digital health products and solutions. Here are three fundamental reasons for engaging clinicians.

1) Delivering actionable, personalized patient data

Clinicians value relevant, actionable, and contextual data that helps with their decision-making per patient. Delivering clinical teams loads data surely sounds good on paper, but it ends up hindering their decision-making if not presented, shared, and configured contextually.

A Q3 2021 survey conducted by Accenture confirmed that clinicians are interested in digital health technologies and integrations; however, over 60 percent said the lack of interoperability between IT systems that they use daily is a top reason for not rolling out daily digital health

within their systems. This kind of boots-on-the-ground feedback is highly valuable for applying new technologies to real-world applications.

2) Understand Clinicians’ Day-to-day

Creating technologies, digital health applications, and health AI that helps clinicians be more proactive towards patient care daily is essential because care teams are integral components to delivering better outcomes during patients’ medical journeys.

Even though EMR platforms have become a standard operational platform in most healthcare settings, they will continue to require additional enhancements and health data integrations from digital health companies to make it the end-to-end platform needed for clinical decision-making and delivering enhanced patient outcomes.

Examples of some digital health technologies like Neurable, Cerebral, Hippo technologies, and iRhythm Technologies, to name a few, are leading the pack in getting clinicians involved early. By working alongside them to understand clinical challenges in the field and create digital pathway solutions to work within their current workflows to provide their digital health solutions that ultimately lead to better patient outcomes.

3) Building tools that enhance clinical decision making across the patient journey

Using Artificial Intelligence, Machine Learning, and operational technology for healthcare can help medical experts further their patient-data knowledge and accelerate their decision-making.

Digital integrations in healthcare have repeatedly shown that they can enhance patient engagement and create tremendous acceleration in early detection for chronic conditions and disease deterioration by clinical teams. Still, these building blocks and tools must connect to facilitate clinical engagement, as well.

Think of a day when there is a “personalized patient-centric” on-demand clinical model. Where AI, wearables, connected and digital health all work together in real-time to detect early signs of disease onset in a patient, and through pre-established clinical workflows and patient-centric pathways, medication or therapies are delivered directly to the patient fully approved through their payor

Now that is the magical intersection of a patient, provider, payor, and digital technology at our fingertips!

Editor’s Note: Arti Bedi Pullins is a strategic, data-driven entrepreneur with 20 years of experience in business strategy and deployment, product innovation and digital marketing. Her passion sits at the intersection of customer-based design-thinking, innovative technology, and market data/research.

Arti has architected and led over a dozen technology businesses towards successful growth, applied market, customer, and product research data to the development of in-market execution, and worked on minimizing risk and unnecessary costs by understanding how consumers’ emotions, interactions, cultural and socio-economic demographics impact brand engagement and adoption.

In 2017, Arti founded Pundit Consultantz, a healthcare innovation, and creative services design consultancy. Pundit Consultantz is the change agent and problem solver for healthcare and life sciences clients. The firm works exclusively with healthcare companies to incubate, innovate, and digitally transform. Pundit Consultantz helps businesses, institutions and developers in healthcare and life sciences technology ideate and then build products and services with real-world applications to produce better outcomes. The company also has creative design services that executes practical go-to-market strategies for clients’ products and services.

Prior to founding her business consultancy, Arti held senior leadership roles with SessionM, Glassdoor and CareerBuilder.com. She earned an MBA from the Kellogg School of Management at Northwestern University, and a bachelor’s degree in business communication from Michigan State University.

In addition to English, Arti is fluent in Hindi and Punjabi.

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy